Nanomaterial-Based Strategies to Combat Antibiotic Resistance: Mechanisms and Applications

Overview

Journal Antibiotics (Basel)

Specialty Pharmacology

Date 2025 Feb 26

PMID 40001450

Authors

Nargish Parvin

Sang Woo Joo

Tapas K Mandal

Affiliations

Soon will be listed here.

Abstract

The rapid rise of antibiotic resistance has become a global health crisis, necessitating the development of innovative strategies to combat multidrug-resistant (MDR) pathogens. Nanomaterials have emerged as promising tools in this fight, offering unique physicochemical properties that enhance antibiotic efficacy, overcome resistance mechanisms, and provide alternative therapeutic approaches. This review explores the diverse nanomaterial-based strategies used to combat antibiotic resistance, focusing on their mechanisms of action and practical applications. Nanomaterials such as metal nanoparticles, carbon-based nanomaterials, and polymeric nanostructures exhibit antibacterial properties through various pathways, including the generation of reactive oxygen species (ROS), disruption of bacterial membranes, and enhancement of antibiotic delivery. Additionally, the ability of nanomaterials to bypass traditional resistance mechanisms, such as biofilm formation and efflux pumps, has been demonstrated in numerous studies. This review also discusses the synergistic effects observed when nanomaterials are combined with conventional antibiotics, leading to increased bacterial susceptibility and reduced required dosages. By highlighting the recent advancements and clinical applications of nanomaterial-antibiotic combinations, this paper provides a comprehensive overview of how nanomaterials are reshaping the future of antibacterial therapies. Future research directions and challenges, including toxicity and scalability, are also addressed to guide the development of safer, more effective nanomaterial-based antibacterial treatments.

References

Cheesman M, Ilanko A, Blonk B, Cock I . Developing New Antimicrobial Therapies: Are Synergistic Combinations of Plant Extracts/Compounds with Conventional Antibiotics the Solution?. Pharmacogn Rev. 2017; 11(22):57-72. PMC: 5628525. DOI: 10.4103/phrev.phrev_21_17. View

Barua S, Mitragotri S . Challenges associated with Penetration of Nanoparticles across Cell and Tissue Barriers: A Review of Current Status and Future Prospects. Nano Today. 2014; 9(2):223-243. PMC: 4129396. DOI: 10.1016/j.nantod.2014.04.008. View

Leon-Buitimea A, Garza-Cardenas C, Roman-Garcia M, Ramirez-Diaz C, Ulloa-Ramirez M, Morones-Ramirez J . Nanomaterials-Based Combinatorial Therapy as a Strategy to Combat Antibiotic Resistance. Antibiotics (Basel). 2022; 11(6). PMC: 9220075. DOI: 10.3390/antibiotics11060794. View

Siwal S, Sheoran K, Mishra K, Kaur H, Saini A, Saini V . Novel synthesis methods and applications of MXene-based nanomaterials (MBNs) for hazardous pollutants degradation: Future perspectives. Chemosphere. 2022; 293:133542. DOI: 10.1016/j.chemosphere.2022.133542. View

Salama B, Alzahrani K, Alghamdi K, Al-Amer O, Hassan K, Elhefny M . Silver Nanoparticles Enhance Oxidative Stress, Inflammation, and Apoptosis in Liver and Kidney Tissues: Potential Protective Role of Thymoquinone. Biol Trace Elem Res. 2022; 201(6):2942-2954. DOI: 10.1007/s12011-022-03399-w. View

Mehrotra R, Cukor D, McCurry S, Rue T, Roumelioti M, Heagerty P . Effectiveness of Existing Insomnia Therapies for Patients Undergoing Hemodialysis : A Randomized Clinical Trial. Ann Intern Med. 2024; 177(2):177-188. DOI: 10.7326/M23-1794. View

Mitchell M, Billingsley M, Haley R, Wechsler M, Peppas N, Langer R . Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2020; 20(2):101-124. PMC: 7717100. DOI: 10.1038/s41573-020-0090-8. View

Avakh A, Grant G, Cheesman M, Kalkundri T, Hall S . The Art of War with : Targeting Mex Efflux Pumps Directly to Strategically Enhance Antipseudomonal Drug Efficacy. Antibiotics (Basel). 2023; 12(8). PMC: 10451789. DOI: 10.3390/antibiotics12081304. View

Mammari N, Lamouroux E, Boudier A, Duval R . Current Knowledge on the Oxidative-Stress-Mediated Antimicrobial Properties of Metal-Based Nanoparticles. Microorganisms. 2022; 10(2). PMC: 8877623. DOI: 10.3390/microorganisms10020437. View

10.

Ali A, Al Bostami R, Al-Othman A . Nanogel-based composites for bacterial antibiofilm activity: advances, challenges, and prospects. RSC Adv. 2024; 14(15):10546-10559. PMC: 10985586. DOI: 10.1039/d4ra00410h. View

11.

Lai R, Yeung K, Yung M, Djurisic A, Giesy J, Leung K . Regulation of engineered nanomaterials: current challenges, insights and future directions. Environ Sci Pollut Res Int. 2017; 25(4):3060-3077. DOI: 10.1007/s11356-017-9489-0. View

12.

Manyi-Loh C, Mamphweli S, Meyer E, Okoh A . Antibiotic Use in Agriculture and Its Consequential Resistance in Environmental Sources: Potential Public Health Implications. Molecules. 2018; 23(4). PMC: 6017557. DOI: 10.3390/molecules23040795. View

13.

Sadeghi S, Agharazi F, Ali Hosseinzadeh S, Mashayekhi M, Saffari Z, Shafiei M . Gold nanoparticle conjugation enhances berberine's antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA). Talanta. 2023; 268(Pt 1):125358. DOI: 10.1016/j.talanta.2023.125358. View

14.

Karnwal A, Kumar G, Pant G, Hossain K, Ahmad A, Alshammari M . Perspectives on Usage of Functional Nanomaterials in Antimicrobial Therapy for Antibiotic-Resistant Bacterial Infections. ACS Omega. 2023; 8(15):13492-13508. PMC: 10116640. DOI: 10.1021/acsomega.3c00110. View

15.

Elston R, Mulligan C, Thomas G . Flipping the switch: dynamic modulation of membrane transporter activity in bacteria. Microbiology (Reading). 2023; 169(11). PMC: 10710835. DOI: 10.1099/mic.0.001412. View

16.

Gonzalez Gomez A, Hosseinidoust Z . Liposomes for Antibiotic Encapsulation and Delivery. ACS Infect Dis. 2020; 6(5):896-908. DOI: 10.1021/acsinfecdis.9b00357. View

17.

Dakal T, Kumar A, Majumdar R, Yadav V . Mechanistic Basis of Antimicrobial Actions of Silver Nanoparticles. Front Microbiol. 2016; 7:1831. PMC: 5110546. DOI: 10.3389/fmicb.2016.01831. View

18.

Birk S, Boisen A, Nielsen L . Polymeric nano- and microparticulate drug delivery systems for treatment of biofilms. Adv Drug Deliv Rev. 2021; 174:30-52. DOI: 10.1016/j.addr.2021.04.005. View

19.

Makabenta J, Nabawy A, Li C, Schmidt-Malan S, Patel R, Rotello V . Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections. Nat Rev Microbiol. 2020; 19(1):23-36. PMC: 8559572. DOI: 10.1038/s41579-020-0420-1. View

20.

Ciofu O, Tolker-Nielsen T, Jensen P, Wang H, Hoiby N . Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients. Adv Drug Deliv Rev. 2014; 85:7-23. DOI: 10.1016/j.addr.2014.11.017. View